Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors
(Q37446311)
scientific article published on 03 January 2014
scientific article published on 03 January 2014
Language:
Current Data About
Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors
other details
description | scientific article published on 03 January 2014 |
External Links
(P356) |
10.1186/1756-8722-7-1
|
(P698) |
24387695
|
(P932) |
3884022
|
(P5875) |
259586026
|
(P6179) |
1033613173
|